Health systems use 340B to expand "their profit and monopoly power," Trump administration CMS Administrator Seema Verma said in a Wall Street Journal op-ed.
Seema Verma, ex-President Trump’s Centers for Medicare & Medicaid Services administrator, said in a Wall Street Journal op-ed yesterday that large health systems work to expand their use of the 340B program “and thus their profit and monopoly
A CV340B social media graphic promoting its Aug. 3 march on Capitol Hill "to defend 340B."
Advocacy organization Community Voices for 340B (CV340B) is hosting a march to the U.S. Capitol “to defend 340B” on Aug. 3 just after the 340B Coalition annual summer meeting in nearby National Harbor, Md., concludes.
340B Report's May 18 webinar panelists included (clockwise from top left) Aaron Vandervelde, Jason Atlas, Ashley Mains Espinosa, Tom Mirga, Ted Slafsky, and Sue Veer.
340B Report held a webinar for its subscribers last week on Second Sight Solutions’ 340B ESP platform that administers drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies. More than 800 subscribers registered to attend—a
Industry-supported consumer protection group National Consumers League sharply criticized 340B hospitals and contract pharmacies in a recent opinion article for a conservative-leaning news site.
America’s oldest consumer protection group, shunned by some former allies in the labor movement for alleged favoritism toward its corporate donor Amazon, has slammed the 340B program in a commentary for the conservative-leaning news and opinion website RealClearHealth.
Charity care at five Massachusetts hospital groups declined at a time that 340B sales to the hospitals were rising, a new report by a conservative state think tank says. The state hospital association says the report distorts the 340B program.
Charity care has been declining significantly in some Massachusetts hospital systems, raising “a significant policy issue for the 340B program,” a free-market-oriented Massachusetts think tank whose donors include pharmaceutical manufacturers says in a new report.
AHF held a demonstration in front of Gilead's headquarters protesting the company’s new conditions on 340B contract pharmacy pricing on its branded hepatitis C treatments.
UPDATE Thursday, March 24, 2022, 2:10 p.m.—A Gilead spokesperson disputed AIDS Healthcare Foundation’s statement that, under Gilead’s new conditions on 340B contract pharmacy pricing on its branded hepatitis C treatments, the company will give 340B discounts to covered
An AIDS Healthcare Foundation activist handed out Let it B signs supporting the 340B program during a September 2021 protest in front of U.S. Rep. Scott Peters' (D-Calif.) district office in San Diego.
AIDS Healthcare Foundation (AHF) today criticized efforts to introduce federal legislation to address drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies. It said the drug industry “will certainly use any legislation as an opportunity
The Institute for Clinical and Economic Review has tentatively concluded that four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients.
The Institute for Clinical and Economic Review (ICER) has issued a draft report concluding four drugs have demonstrated effectiveness and value in reducing hospitalizations of COVID-19 patients. The independent nonprofit group evaluates prescription drugs and medical treatments’
The Carl Taylor Pharmacy Administration Scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy was announced this morning at the 340B Coalition Winter Conference in San Diego. Taylor, 76, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C., died last Sept. 24.
An endowed scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy has been established in memory of Carl Taylor, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C. Taylor, age 76, died